Diagnosis and classification of autoimmune blistering diseases

Autoimmunity Reviews

Volumn 13, Issue 4-5, 2014, Pages 482-489

  Baum, Sharon ^a   Sakka, Nicole ^a   Artsi, Ofir ^a   Trau, Henri ^a   Barzilai, Aviv ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Autoantibodies; Blistering skin diseases; Direct immunofluorescence; Pemphigoid; Pemphigus

Indexed keywords

BLISTER; BULLOUS PEMPHIGOID; DERMATITIS HERPETIFORMIS; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMOLYSIS BULLOSA ACQUISITA; ERYTHEMATOUS PEMPHIGUS; HISTOLOGY; HUMAN; IGA PEMPHIGUS; IMMUNOFLUORESCENCE MICROSCOPY; INCIDENCE; LINEAR IGA BULLOUS DERMATOSIS; MUCOSA; MUCOUS MEMBRANE PEMPHIGOID; PARANEOPLASTIC PEMPHIGUS; PEMPHIGOID GESTATIONIS; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; REVIEW; WESTERN BLOTTING;

AUTOANTIBODIES; BLISTERING SKIN DISEASES; DIRECT IMMUNOFLUORESCENCE; PEMPHIGOID; PEMPHIGUS;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; EPIDERMIS; HUMANS; IMMUNOGLOBULIN A; PEMPHIGOID, BULLOUS; PROGNOSIS;

EID: 84896263251     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2014.01.047     Document Type: Review

References (45)

1. Kneisel A., Hertl M. Autoimmune bullous skin diseases. Part 1: clinical manifestations. J Dtsch Dermatol Ges 2011, 9:844-856.
2. Sticherling M., Erfurt-Berge C. Autoimmune blistering diseases of the skin. Autoimmun Rev 2012, 11:226-230.
3. Bystryn J.C., Rudolph J.L. Pemphigus. Lancet 2005, 366:61-73.
4. Knudson R.M., Kalaaji A.N., Bruce A.J. The management of mucous membrane pemphigoid and pemphigus. Dermatol Ther 2010, 23:268-280.
5. Goon A.T., Tan S.H. Comparative study of pemphigus vulgaris and pemphigus foliaceus in Singapore. Australas J Dermatol 2001, 42:172-175.
6. Martin L.K., Werth V., Villanueva E., Segall J., Murrell D.F. Interventions for pemphigus vulgaris and pemphigus foliaceus. Cochrane Database Syst Rev 2009, 21. [CD006263].
7. Tsuruta D., Ishii N., Hamada T., Ohyama B., Fukuda S., Koga H., et al. IgA pemphigus. Clin Dermatol 2011, 29:437-442.
8. Zimmermann J., Bahmer F., Rose C., Zillikens D., Schmidt E. Clinical and immunopathological spectrum of paraneoplastic pemphigus. J Dtsch Dermatol Ges 2010, 8:598-606.
9. Anhalt G.J., Kim S.C., Stanley J.R., Korman N.J., Jabs D.A., Kory M., et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990, 323:1729-1735.
10. Robinson N.D., Hashimoto T., Amagai M., Chan L.S. The new pemphigus variants. J Am Acad Dermatol 1999, 40:649-671.
11. Rivollier C., Vaillant L., Machet M.C., Martin L., Jan V., Huttenberger B., et al. Paraneoplastic pemphigus: a pustular form during chronic lymphoid leukemia. Ann Dermatol Venereol 2001, 128:644-648.
12. Wang J., Zhu X., Li R., Tu P., Wang R., Zhang L., et al. Paraneoplastic pemphigus associated with Castleman tumor: a commonly reported subtype of paraneoplastic pemphigus in China. Arch Dermatol 2005, 141:1285-1293.
13. Vezzoli P., Berti E., Marzano A.V. Rationale and efficacy for the use of rituximab in paraneoplastic pemphigus. Expert Rev Clin Immunol 2008, 4(3):351-364.
14. Park G.T., Lee J.H., Yun S.J., Lee J.B. Paraneoplastic pemphigus without an underlying neoplasm. Br J Dermatol 2007, 156:725-732.
15. Wang L., Bu D., Yang Y. Castleman's tumours and production of autoantibody in paraneoplastic pemphigus. Lancet 2004, 363:525-531.
16. Schmidt E., della Torre R., Borradori L. Clinical features and practical diagnosis of bullous pemphigoid. Dermatol Clin 2011, 29:427-438.
17. Bernard P., Vaillant L., Labeille B., Bedane C., Arbeille B., Denoeux J.P., et al. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. French Bullous Study Group. Arch Dermatol 1995, 131(1):48-52.
18. Kirtschig G., Middleton P., Bennett C., Murrell D.F., Wojnarowska F., Khumalo N.P. Interventions for bullous pemphigoid. Cochrane Database Syst Rev 2010, 6. [CD002292].
19. Korman N. Bullous pemphigoid. J Am Acad Dermatol 1987, 16:907-924.
20. Schmidt E., Sitaru C., Schubert B., Wesselmann U., Kromminga A., Bröcker E.B., et al. Subacute prurigo variant of bullous pemphigoid: autoantibodies show the same specificity compared with classic bullous pemphigoid. J Am Acad Dermatol 2002, 47:133-136.
21. Geiss Steiner J., Trueb R.M., Kerl K., Mühleisen B., French L.E., Hofbauer G.F. Ecthyma gangrenosum-like bullous pemphigoid. Dermatology 2010, 221:142-148.
22. Mondino B.J., Sutart I.B. Ocular cicatricial pemphigoid. Ophthalmology 1981, 88:95-100.
23. Ahmed A.R., Hombal S.M. Cicatricial pemphigoid. Int J Dermatol 1986, 25:90-96.
24. Laskaris G., Sklavounou A., Stratigos J. Bullous pemphigoid, cicatricial pemphigoid and pemphigus vulgaris: a comparative clinical survey of 278 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1982, 54:656-662.
25. Venning V.A. Linear IgA disease: clinical presentation, diagnosis, and pathogenesis. Dermatol Clin 2011, 29:453-458.
26. Godfrey K., Wojnarowska F., Leonard J. Linear IgA disease of adults: association with lymphoproliferative malignancy and possible role of other triggering factors. Br J Dermatol 1990, 123:447-452.
27. Jacyk W.K., Nagel G.J., van der Hoven A.E. Linear IgA dermatosis and Hodgkin's lymphoma - report of a case in an African and review of the literature. J Dermatol 1990, 17:633-637.
28. Usmani N., Baxter K.F., Child J.A., Sheehan-Dare R. Linear IgA disease in association with chronic lymphocytic leukaemia. Br J Dermatol 2004, 151:710-711.
29. Bertram F., Bror̈cker E.B., Zillikens D., Schmit E. Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. J Dtsch Dermatol Ges 2009, 7(5):434-440.
30. Caux F. Diagnosis and clinical features of epidermolysis bullosa acquisita. Dermatol Clin 2011, 29:485-491.
31. Kárpáti S. Dermatitis herpetiformis. Clin Dermatol 2012, 30:56-59.
32. Kneisel A., Hertl M. Autoimmune bullous skin diseases. Part2: diagnosis and therapy. J Dtsch Dermatol Ges 2011, 9:927-947.
33. Rose C., Bröcker E.B., Zillikens D. Clinical, histological and immunopathological findings in 32 patients with dermatitis herpetiformis Duhring. J Dtsch Dermatol Ges 2010, 8:265-267.
34. Bolotin D A., Petronic-Rosic V. Dermatitis herpetiformis. Part I. Epidemiology, pathogenesis, and clinical presentation. J Am Acad Dermatol 2011, 64:1017-1024.
35. Lever's histopathology of the skin 2009, Wolters Kluwer Health/Lippincott Williams &Wilkins, Philadelphia. W.F. Lever, D.E. Elder (Eds.).
36. Schmidt E., Zillikens D. Modern diagnosis of autoimmune blistering skin diseases. Autoimmun Rev 2010, 10:84-89.
37. Bystryn J.C. Interpretation of immunofluorescence tests in dermatology. Prog Dermatol 1985, 19:1-8.
38. De A., Rao R., Balachandran C. Salt split technique: a useful tool in the diagnosis of subepidermal bullous disorders. Indian J Dermatol 2010, 55(4):334-336.
39. Pohla-Gubo G., Hintner H. Direct and indirect immunofluorescence for the diagnosis of bullous autoimmune diseases. Dermatol Clin Jul 2011, 29(3):365-372.
40. Schmidt E., Obe K., Brocker E.B., Zillikens D. Serum levels of autoantibodies to BP180correlate with disease activity in patients with bullous pemphigoid. Arch Dermatol 2000, 136:174-178.
41. Chan L.S., Ahmed A.R., Anhalt G.J., Bernauer W., Cooper K.D., Elder M.J., et al. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol 2002, 138(3):370-379.
42. Marinkovich M.P., Taylor T.B., Keene D.R., Burgeson R.E., Zone J.J. LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells. J Invest Dermatol 1996, 106:734-738.
43. Zillikens D., Herzele K., Georgi M., Schmidt E., Chimanovitch I. Schuman autoantibodies in a subgroup of patients with linear IgA disease react with theNC16A domain of BP1801. J Invest Dermatol 1999, 113:947-953.
44. Lapiere J.C., Woodley D.T., Parente M.G., Iwasaki T., Wynn K.C., Christiano A.M., et al. Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J Clin Invest 1993, 92:1831-1839.
45. Rose C., Armbruster F.P., Ruppert J., Igl B.W., Zillikens D., Shimanovich I. Autoantibodies against epidermal transglutaminase are a sensitive diagnostic marker in patients with dermatitis herpetiformis on a normal or gluten-free diet. J Am Acad Dermatol 2009, 61:39-43.